Higher doses of valsartan ( 640mg ) demonstrated additional reductions in SBP among the prompt responders and led to greater SBP reductions from baseline ( 19.8 mmHg ) compared with valsartan 160 ( 14.4 mmHg , P < 0.05 ) and 320mg ( 16.5 mmHg ) .
